DONADON, Matteo Davide
 Distribuzione geografica
Continente #
NA - Nord America 11.503
AS - Asia 5.848
EU - Europa 2.177
SA - Sud America 1.261
AF - Africa 294
Continente sconosciuto - Info sul continente non disponibili 222
OC - Oceania 8
AN - Antartide 1
Totale 21.314
Nazione #
US - Stati Uniti d'America 11.213
SG - Singapore 3.628
BR - Brasile 1.053
CN - Cina 915
IT - Italia 632
VN - Vietnam 535
FI - Finlandia 344
IE - Irlanda 261
DE - Germania 199
NG - Nigeria 184
FR - Francia 160
CA - Canada 152
HK - Hong Kong 146
GB - Regno Unito 131
IN - India 102
NL - Olanda 93
BD - Bangladesh 82
TR - Turchia 78
AR - Argentina 76
SE - Svezia 72
RU - Federazione Russa 56
AE - Emirati Arabi Uniti 54
IQ - Iraq 53
MX - Messico 53
BE - Belgio 47
EC - Ecuador 36
ZA - Sudafrica 35
PL - Polonia 29
IL - Israele 26
PK - Pakistan 26
UA - Ucraina 26
ID - Indonesia 25
UZ - Uzbekistan 25
JP - Giappone 24
CO - Colombia 23
ES - Italia 23
CR - Costa Rica 19
MA - Marocco 19
CL - Cile 18
NP - Nepal 17
PY - Paraguay 16
VE - Venezuela 16
PH - Filippine 13
BG - Bulgaria 12
KE - Kenya 12
CZ - Repubblica Ceca 11
DZ - Algeria 10
MY - Malesia 9
PE - Perù 9
PT - Portogallo 9
SA - Arabia Saudita 9
UY - Uruguay 9
AT - Austria 8
DO - Repubblica Dominicana 8
GT - Guatemala 8
HN - Honduras 8
JO - Giordania 8
RO - Romania 8
SV - El Salvador 8
TN - Tunisia 8
AU - Australia 7
AZ - Azerbaigian 7
CH - Svizzera 7
IR - Iran 7
LT - Lituania 7
NI - Nicaragua 7
AL - Albania 6
GR - Grecia 6
JM - Giamaica 6
OM - Oman 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
EG - Egitto 5
KG - Kirghizistan 5
KR - Corea 5
KZ - Kazakistan 5
PR - Porto Rico 5
SN - Senegal 5
AO - Angola 4
BO - Bolivia 4
EE - Estonia 4
EU - Europa 4
LB - Libano 4
PA - Panama 4
PS - Palestinian Territory 4
TH - Thailandia 4
BH - Bahrain 3
BY - Bielorussia 3
ET - Etiopia 3
GE - Georgia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
LV - Lettonia 2
MD - Moldavia 2
Totale 21.066
Città #
Singapore 1.640
Wilmington 1.300
Chandler 1.158
San Jose 612
Ashburn 546
The Dalles 537
San Mateo 498
Dallas 409
Shanghai 404
Ann Arbor 352
Helsinki 342
Council Bluffs 292
Dublin 256
Princeton 254
Leawood 234
Milan 234
New York 229
Lawrence 228
Beijing 226
Boardman 195
Benin City 183
Ho Chi Minh City 179
Hong Kong 139
Fairfield 131
Los Angeles 126
Paris 125
Santa Clara 125
Hanoi 117
Woodbridge 103
São Paulo 96
Phoenix 92
Amsterdam 82
Rome 79
Toronto 77
London 64
Seattle 61
Brussels 46
Kocaeli 45
North Bergen 44
Columbus 41
Buffalo 40
Chicago 38
Houston 35
Orem 34
Rio de Janeiro 34
San Diego 34
Brooklyn 33
Norwalk 31
Atlanta 28
Belo Horizonte 25
Tashkent 25
Warsaw 25
Munich 24
Queens 24
Baghdad 23
Miami 23
Tokyo 23
Chennai 22
Da Nang 22
Falkenstein 22
Naples 21
Boston 20
Haiphong 20
Las Vegas 20
Brasília 19
Johannesburg 19
Figino 18
San Francisco 18
Frankfurt am Main 16
The Bronx 16
Florence 15
Monmouth Junction 15
Montreal 15
Philadelphia 15
Abbiategrasso 14
Charlotte 14
Washington 14
Biên Hòa 13
Mexico City 13
Salvador 13
San José 13
Buenos Aires 12
Cambridge 12
Denver 12
Dhaka 12
Porto Alegre 12
Turin 12
Detroit 11
Guayaquil 11
Mumbai 11
Quito 11
Richmond 11
Campinas 10
Cincinnati 10
Falls Church 10
Goiânia 10
Istanbul 10
Lahore 10
Moscow 10
Pittsburgh 10
Totale 13.014
Nome #
Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy 209
Back-flow bleeding control during resection of right-sided liver tumors by means of ultrasound-guided finger compression of the right hepatic vein at its caval confluence 162
Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy? 157
A Phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of non-oncogenic RTKs 156
Anatomical resection of segment 8 by means of ultrasound-guided vessel compression 145
Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis 136
AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS. 130
Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients 127
Safety of intermittent pringle maneuver cumulative time exceeding 120 minutes in liver resection : a further step in favor of the "radical but conservative" policy 127
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers : is it adherent to the EASL/AASLD recommendations? : an observational study of the HCC east-west study group 126
B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury 124
"Radical but conservative" is the main goal for ultrasonography-guided liver resection : prospective validation of this approach 123
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine 120
Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients : a multivariate analysis 119
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 119
Hepatic resection for hepatocellular carcinoma in cirrhosis 118
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 116
A new systematic small for size resection for liver tumors invading the middle hepatic vein at its caval confluence: mini-mesohepatectomy 116
Anatomical right posterior sectionectomy: a further expansion of the ultrasound-guided compression technique 115
Does Inferior-Vena-Cava Collapsibility Correlate with Fluid Regimen and Outcome in Patients Undergoing Liver Resection? 115
Anatomical segmental and subsegmental resection of the liver for hepatocellular carcinoma: a new approach by means of ultrasound - guided vessel compression 114
[Surgical treatment of liver metastases from colorectal carcinoma]. 113
A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives 112
Survivin gene expression in chronic liver disease and hepatocellular carcinoma 111
Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence 110
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group Reply 110
Surgery for cholangiocarcinoma 110
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 109
Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis : is it useful or useless? A prospective cohort study of our experience 108
Prediction of remnant liver volume using 3D simulation software in patients undergoing R1vasc parenchyma-sparing hepatectomy for multiple bilobar colorectal liver metastases: reliability, clinical impact, and learning curve 108
Right inferior phrenic vein indicating the right hepatic vein confluence into the inferior vena cava 106
Inferior vena cava thrombosis : an unusual complication of a large simple non-parasitic liver cyst requiring an integrated approach 106
Bevacizumab Improves Pathologic Response and Protects against Hepatic Injury in Patients Treated with Oxaliplatin-based Chemotherapy for Colorectal Liver Metastases 106
Cholinesterases Predict Outcome in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma, Results From a Retrospective Analysis 106
Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases 106
Hepatectomy for hepatocellular carcinoma in stage B and C of BCLC classification: A feasible, safe, and effective treatment 105
The role of natural killer cells in autoimmune lIver disease : a comprehensive review 103
Technical tricks for radical but conservative liver resection. The ultrasound guidance 102
Twelve-year experience of "radical but conservative" liver surgery for colorectal metastases: impact on surgical practice and oncologic efficacy 102
Safe Hepatectomy Selection Criteria for Hepatocellular Carcinoma Patients: A Validation of 336 Consecutive Hepatectomies. The BILCHE Score 102
Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications 102
Conservative Hepatectomy for Tumors Involving the Middle Hepatic Vein and Segment 1: The Liver Tunnel 101
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 101
Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases 100
Surgical strategy for liver tumors located at the hepato-caval confluence 100
An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma 100
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 99
Utility of the hooking technique for cases of major hepatectomy 98
Systematic extended right posterior sectionectomy: a safe an effective alternative to righ hepatectomy 97
Monopolar floating ball versus bipolar forceps for hepatic resection: a prospective randomized clinical trial 97
Ultrasound guided liver resection: Does this approach limit the need for portal vein embolization? 97
Contrast-enhanced intraoperative ultrasonography : a valuable and not any more monocentric diagnostic technique performed in different ways 96
Ultrasound guided liver resection: does this approach limit the need for portal vein embolization? 96
Criteria for the selective use of contrast-enhanced intra-operative ultrasound during surgery for colorectal liver metastases 96
Total or partial anatomical resection of segment 8 using the ultrasound-guided finger compression technique 95
Ultrasound guided liver resection: Does this approach limit the need for portal vein branches embolization? 95
Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study 95
Hepatic vein management in a parenchyma-sparing policy for resecting colorectal liver metastases at the caval confluence 93
Prospective Evaluation of Intrahepatic Microscopic Occult Tumor Foci in Patients with Numerous Colorectal Liver Metastases 93
The surgical margin in liver resection for hepatocellular carcinoma: a real problem or not 93
Approccio al paziente con ittero ostruttivo. 58esimo Capitolo 93
Upper transversal hepatectomy 92
Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy 91
Role of liver biopsy in hepatocellular carcinoma 91
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? 91
Assessment of the American College of Surgeons surgical risk calculator of outcomes after hepatectomy for liver tumors: Results from a cohort of 950 patients 91
Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort 90
Hepatic Vein-Sparing Hepatectomy for Multiple Colorectal Liver Metastases at the Caval Confluence 90
Are Tumor Exposure and Anatomical Resection Antithetical during Surgery for Hepatocellular Carcinoma? A Critical Review 90
Care or palliation for recurrent hepatocarcinoma: a multicentric national analysis of survival 90
Impact of locoregional therapies in patients on the waiting list for liver transplantation. A review of 123 patients transplanted at a single center 90
One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases : a feasible and effective alternative to the 2-stage approach 90
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine 90
ONE STAGE HEPATECTOMY FOR MULTIPLE BILOBAR COLORECTAL LIVER METASTASES 89
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 89
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 89
Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways 88
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis 88
Predicting the Risk of Morbidity by GLIM-Based Nutritional Assessment and Body Composition Analysis in Oncologic Abdominal Surgery in the Context of Enhanced Recovery Programs 87
Liver resection for primary hepatic neuroendocrine tumours : report of three cases and review of the literature 87
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host immune-Centered Factors 87
Radical but Conservative Liver Resection for Large Centrally Located Hepatocellular Carcinoma: The Mini Upper-Transversal Hepatectomy 86
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 86
Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival 85
Macrophages in Colorectal Cancer Liver Metastases 85
R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management 85
Implication of metabolism in the polarization of tumor-associated-macrophages: the mass spectrometry-based point of view 84
The Liver Tunnel Intention-to-treat Validation of a New Type of Hepatectomy 84
Techniques for hepatectomies without blood transfusion, focusing on interpretation of postoperative anemia 84
Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma. A single center observational cohort analysis 84
Vessels encapsulating tumour clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma (HCC) 84
Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure 84
Transarterial Therapies for Hepatocellular Carcinoma 83
Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases 83
Filamin a expression predicts early recurrence of hepatocellular carcinoma 83
Defective DNAM-1 mediated cytotoxicity in NK cells infiltrating hepatocellular carcinoma 83
CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study 83
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma 83
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma 83
Tailoring the area of hepatic resection using inflow and outflow modulation 82
Totale 10.230
Categoria #
all - tutte 144.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.131 0 0 0 248 9 73 85 164 117 124 249 62
2022/20233.121 522 131 323 339 245 262 0 230 570 279 189 31
2023/20241.621 128 208 346 50 33 177 101 75 27 28 168 280
2024/20253.106 46 67 12 83 67 395 169 287 382 709 487 402
2025/20266.980 1.020 409 441 757 194 280 1.970 334 366 492 211 506
2026/20272.885 626 698 1.134 427 0 0 0 0 0 0 0 0
Totale 21.314